Log in

OTCMKTS:MAMPMedamerica Properties Stock Price, Forecast & News

0.00 (0.00 %)
(As of 12/27/2019)
Today's Range
Now: $3.07
50-Day Range
MA: $3.07
52-Week Range
Now: $3.07
Volume300 shs
Average Volume51 shs
Market Capitalization$8.01 million
P/E RatioN/A
Dividend YieldN/A
MedAmerica Properties Inc., a real estate management company, focuses on investing in commercial real estate properties in the United States. It focuses to acquire medical office buildings. The company was formerly known as Banyan Rail Services Inc. and changed its name to MedAmerica Properties Inc. in June 2017. MedAmerica Properties Inc. was founded in 1985 and is based in Boca Raton, Florida.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.48 out of 5 stars

Industry, Sector and Symbol

Industry Sanitary services
Current SymbolOTCMKTS:MAMP
Previous SymbolOTCMKTS:BARA



Sales & Book Value

Annual SalesN/A
Book Value$0.01 per share


Net Income$-600,000.00


Market Cap$8.01 million
Next Earnings DateN/A
OptionableNot Optionable

Receive MAMP News and Ratings via Email

Sign-up to receive the latest news and ratings for MAMP and its competitors with MarketBeat's FREE daily newsletter.

Medamerica Properties (OTCMKTS:MAMP) Frequently Asked Questions

How has Medamerica Properties' stock been impacted by COVID-19 (Coronavirus)?

Medamerica Properties' stock was trading at $3.07 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MAMP shares have increased by 0.0% and is now trading at $3.07. View which stocks have been most impacted by Coronavirus.

Has Medamerica Properties been receiving favorable news coverage?

News coverage about MAMP stock has trended extremely negative on Wednesday, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Medamerica Properties earned a news sentiment score of -4.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the next few days. View the latest news aboutMedamerica Properties.

Who are some of Medamerica Properties' key competitors?

What other stocks do shareholders of Medamerica Properties own?

Who are Medamerica Properties' key executives?

Medamerica Properties' management team includes the following people:
  • Mr. Joseph C. Bencivenga, Pres , CEO & Director (Age 60)
  • Ms. Patricia K. Sheridan, Chief Financial Officer (Age 57)
  • Mr. Robert I. Schellig Jr., Sr. VP & Gen. Counsel (Age 75)
  • Ms. Natalie Ann Macey, VP of Sales & Marketing
  • Christopher J. Hubbert, Sec.

What is Medamerica Properties' stock symbol?

Medamerica Properties trades on the OTCMKTS under the ticker symbol "MAMP."

How do I buy shares of Medamerica Properties?

Shares of MAMP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Medamerica Properties' stock price today?

One share of MAMP stock can currently be purchased for approximately $3.07.

How big of a company is Medamerica Properties?

Medamerica Properties has a market capitalization of $8.01 million.

What is Medamerica Properties' official website?

The official website for Medamerica Properties is www.medamericaproperties.com.

How can I contact Medamerica Properties?

Medamerica Properties' mailing address is Boca Center Tower 1 5200 Town Center Circle Suite 550, BOCA RATON FL, 33486. The company can be reached via phone at 561-617-8050 or via email at [email protected]

This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.